Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell wall biosynthetic machinery is a complex, multi-step system of enzymes and transporters responsible for creating and maintaining the structural integrity of the bacterial and fungal cell wall (Nature Reviews Microbiology, 2015). In bacteria, this machinery primarily synthesizes peptidoglycan, a mesh-like polymer that protects the cell from osmotic lysis and provides structural support (Journal of Biological Chemistry, 2019). The process involves cytoplasmic synthesis of precursors, their translocation across the inner membrane, and final assembly in the extracytoplasmic space by enzymes such as penicillin-binding proteins (PBPs) (Frontiers in Microbiology, 2021). Because the components of this machinery are essential for microbial survival and lack direct homologs in human cells, they represent some of the most successful targets for antimicrobial therapy (StatPearls, 2023). Drugs targeting this machinery include beta-lactams, which inhibit cross-linking, and glycopeptides, which bind to the peptide precursors to prevent polymerization (StatPearls, 2023). In fungi, the machinery involves the synthesis of chitin and beta-glucans, which are targeted by drugs like echinocandins (Nature Reviews Microbiology, 2017). Therapeutic challenges include the rapid evolution of resistance mechanisms, such as the production of beta-lactamases or the modification of target binding sites (Nature Reviews Microbiology, 2015).
Inhibition of peptidoglycan cross-linking (transpeptidation), inhibition of precursor synthesis (e.g., MurA), inhibition of lipid carrier recycling, or inhibition of fungal 1,3-beta-glucan synthesis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell wall biosynthetic machinery.